Allergic Asthma Natural Treatment
Links shared publicly online about this topic
Asthma
nycallergydoctor.com — “Allergic Asthma Treatment Discussion with NY Allergy Dr Arthur Lubitz” View full resource at nycallergydoctor.com
Most Recently Shared on July 10, 2011 at 2:15 pm By:
View my video on Allergic Asthma here.... http://fb.me/ZLTUM4lw
Study points to key genetic driver of severe allergic asthma
eurekalert.org — “Scientists have identified a genetic basis for determining the severity of allergic asthma in experimental models of the disease. The study may help in the search for future therapeutic strategies to fight a growing medical problem that currently lacks effective treatments, researchers from Cincinnati Children's Hospital Medical Center report in the Aug. 29 Nature Immunology.” View full resource at eurekalert.org
Most Recently Shared on August 29, 2010 at 5:21 pm By:
Study points to key genetic driver of severe allergic asthma: ( Cincinnati Children's Hospital Medical Center ) Sc... http://bit.ly/c5IJpd
Treatment of allergic asthma: Modulation of Th2 cells and their responses
7thspace.com — “Treatment of allergic asthma: Modulation of Th2 cells and their responses - up-to-the-minute news and headlines. 7thSpace is a online portal covering topics such as Family, Business, Entertainment, Headlines, Recipes and more. A place for the whole family featuring many different sections to chose from.” View full resource at 7thspace.com
Most Recently Shared on August 25, 2011 at 11:47 am By:
Treatment of allergic asthma: Modulation of Th2 cells and their responses http://t.co/KN6d3Tp
Is your toddler suffering from food intolerance symptoms? | Allergic Asthma Treatment
allergicasthmatreatment.com — “Check out these symptoms of asthma products: Is your toddler suffering from food intolerance symptoms? Poor sleep, eczema & fussy eating are all possible” View full resource at allergicasthmatreatment.com
Most Recently Shared on June 5, 2011 at 1:27 am By:
Is your toddler suffering from food intolerance symptoms ... http://bit.ly/keR3Na
Quercetin for Allergic Asthma | Health and Wellness News
wellnessresources.com — “For two decades, quercetin has claimed nutritional fame as the most potent natural anti-histamine available. Numerous studies have demonstrated that quercetin reduces allergic immune response by modulating inflammatory signals at the gene level. A new animal study demonstrates that a single dose of quercetin can have a potent bronchodilator effect, offering a potential strategy for people with asthma looking for natural ways to help assist them.” View full resource at wellnessresources.com
Most Recently Shared on March 26, 2012 at 6:24 pm By:
Asthma? Allergies? Here’s a natural way to help calm down allergy-related breathing problems. http://t.co/00HTMiXp
Asthma UK Scotland Comment On The SMC's Approval Of Omalizumab (Xolair) For The Treatment Of Children Aged 6-12 With Severe, Allergic Asthma
medicalnewstoday.com — “Rosie Newbigging, Asthma UK's Executive Director of Nations, Regions & Services, says: 'Asthma UK Scotland fought hard for Xolair to become available for adults and teenagers with severe, allergi” View full resource at medicalnewstoday.com
Most Recently Shared on April 13, 2010 at 3:11 pm By:
Asthma UK Scotland Comment On The SMC's Approval Of Omalizumab (Xolair) For The Treatment Of Children Aged 6-12 With S... http://mnt.to/3B8T
Allergic Asthma Study Breakthrough in the UK | ThirdAge
thirdage.com — “An allergic asthma treatment breakthrough has been discovered by scientists in the UK. Read more at ThirdAge.com.” View full resource at thirdage.com
Most Recently Shared on April 28, 2011 at 10:01 pm By:
Allergic Asthma Study Breakthrough in the UK http://bit.ly/jjb96B
Respiratory Research | Abstract | Treatment of allergic asthma: Modulation of Th2 cells and their responses
respiratory-research.com — “Atopic asthma is a chronic inflammatory pulmonary disease characterised by recurrent episodes of wheezy, laboured breathing with an underlying Th2 cell-mediated inflammatory response in the airways. It is currently treated and, more or less, controlled depending on severity, with bronchodilators e.g. long-acting beta agonists and long-acting muscarinic antagonists or anti-inflammatory drugs such as corticosteroids (inhaled or oral), leukotriene modifiers, theophyline and anti-IgE therapy. Unfort” View full resource at respiratory-research.com
Most Recently Shared on August 29, 2011 at 6:42 pm By:
#respiratoryresearch Treatment of allergic asthma: Modulation of Th2 cells and their responses http://t.co/W3aZMSf
Electroacupuncture Attenuates Ovalbumin-Induced Allergic Asthma via Modulating CD4+CD25+ Regulatory T Cells
hindawi.com — “A mouse pulmonary hypersensitivity experimental model that mimics human asthma was developed, and electroacupuncture (EA) treatment was shown to reduce allergic inflammatory processes. In addition, we also assessed whether the beneficial effects of EA on allergic asthma could be correlated with CD4+CD25+Foxp3+ regulatory T cells (Treg). Cellular profiles and histopathologic analysis demonstrated that peribronchial and perivascular inflammatory cell infiltrates were significantly decreased in the” View full resource at hindawi.com
Most Recently Shared on May 10, 2012 at 5:06 pm By:
Electroacupuncture Attenuates Ovalbumin-Induced Allergic Asthma via Modulating CD4+CD25+ Regulatory T Cells: A m... http://t.co/Pboaf4Ta
Cytos Biotechnology Presents Novel Toll-Like Receptor 9 Agonist CYT003-QbG10 for the Treatment of Allergic Asthma at the 2010 Annual Conference of the European Respiratory Society - Drugs.com MedNews
drugs.com — “Barcelona, Spain and Schlieren (Zurich), Switzerland, September 21, 2010 Cytos Biotechnology Ltd (SIX CYTN) announced today that clinical results with CYT003-Qb” View full resource at drugs.com
Most Recently Shared on September 21, 2010 at 9:11 pm By:
Cytos Biotechnology Presents Novel Toll-Like Receptor 9 Agonist CYT003-QbG10 for the Treatment of Allergic As... http://bit.ly/c9v3ne #drug
PharmaLive: Cytos Biotechnology Presents Novel Toll-Like Receptor 9 Agonist CYT003-QbG10 for the Treatment of Allergic Asthma at the 2010 Annual Conference of the European Respiratory Society
pharmalive.com — “PharmaLive: Cytos Biotechnology Presents Novel Toll-Like Receptor 9 Agonist CYT003-QbG10 for the Treatment of Allergic Asthma at the 2010 Annual Conference of the European Respiratory Society” View full resource at pharmalive.com
Most Recently Shared on September 26, 2010 at 12:59 pm By:
Cytos Biotechnology Presents Novel Toll-Like Receptor 9 Agonist CYT003-QbG10 for the Treatment of Allergic Asthma http://is.gd/ftW2p
PharmaLive: Cytos Biotechnology establishes strong patent position around core technology for CYT003-QbG10 in the treatment of allergic asthma and rhinitis
pharmalive.com — “PharmaLive: Cytos Biotechnology establishes strong patent position around core technology for CYT003-QbG10 in the treatment of allergic asthma and rhinitis” View full resource at pharmalive.com
Most Recently Shared on September 29, 2010 at 11:36 pm By:
Cytos Biotechnology establishes strong patent position around CYT003-QbG10 in the treatment of asthma and rhinitis http://is.gd/fB9Xt
Novartis Disappointed by Initial NICE Decision on Xolair(R) (omalizumab)[1] and Concerned that Children Suffering from Severe Persistent Allergic Asthma will be Denied Access to Treatment[1] - News Press Release | PharmiWeb.com
pharmiweb.com — “PR NewswireFRIMLEY, England, June 1, 2010FRIMLEY, England, June 1, 2010 /PRNewswire/ -- - Just for UK media, not for Ireland - This release is intended for consumer media - Add-On Omalizumab Reduces the Rate of Asthma Attacks in Children Aged 6” View full resource at pharmiweb.com
Most Recently Shared on June 1, 2010 at 10:25 am By:
Press Release: Novartis is disappointed that the National Institute for Health and Clinical Excellence (NICE) has ... http://bit.ly/9Aw1Xt
Study Points to Genetic Driver of Severe Asthma
newswise.com — “Scientists have identified a genetic basis for determining the severity of allergic asthma in experimental models of the disease. The study may help in the search for future therapeutic strategies to fight a growing medical problem that currently lacks effective treatments.” View full resource at newswise.com
Most Recently Shared on August 29, 2010 at 6:21 pm By:
Study Points to Genetic Driver of Severe Asthma: Scientists have identified a genetic basis for determining the se... http://bit.ly/bG5PeP
Study Points to Genetic Driver of Severe Asthma
newswise.com — “Scientists have identified a genetic basis for determining the severity of allergic asthma in experimental models of the disease. The study may help in the search for future therapeutic strategies to fight a growing medical problem that currently lacks effective treatments.” View full resource at newswise.com
Most Recently Shared on August 29, 2010 at 11:22 pm By:
Study Points to Genetic Driver of Severe Asthma: Scientists have identified a genetic basis for determining the se... http://bit.ly/c45EgV
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Dr. Arthur Lubitz
Treating NY Allergy sufferers for over 25 years, Dr. Lubitz successfully applies the latest in medical science and devises easy to follow and easy to understand treatment plans. Suffering with allergies, asthma, sinus problems and/or immunological conditions, Dr. Lubitz will help you achieve a better lifestyle free from symptoms which interfer in your life. Dr. Lubitz is Board Certified Allergy Specialist, NYU Medical Instructor and the NY Allergy, Asthma & Sinus Care expert. Once again named a NY Best Allergist by Castle and Connelly, Dr Lubitz is also a perennial Patients Choice Award recipient.
-
Genetics OW
Organizing genetics resources shared by health experts, advocates, and organizations into WisdomCards.
-
Michael Blaiss, MD
Allergist. Past President of the American College of Allergy, Asthma, and Immunology
Advertisement

